The Street Is Finally Waking Up To West Pharmaceutical Services, Inc. (NYSE: WST)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed West to Host Fourth-Quarter and Full-Year 2023 Conference Call.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

West Pharmaceutical Services, Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. The current market capitalization of West Pharmaceutical Services, Inc. is $29.42B. A total of 0.92 million shares were traded on the day, compared to an average of 428.91K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, WST has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 43 BUYs and 43 SELLs from insiders. Insiders purchased 264,965 shares during that period but sold 217,611.

In the most recent transaction, Winters Chad sold 1,013 shares of WST for 349.00 per share on Dec 01. After the transaction, the VP, Chief Accounting Officer now owns 1,270 company shares. In a previous transaction on Oct 31, Witherspoon Charles sold 1,190 shares at 322.37 per share. WST shares that VP & Treasurer owns now total 1,835.

Among the insiders who sold shares, Favorite Annette F disposed of 2,000 shares on Aug 30 at a per-share price of $414.64. This resulted in the Sr. VP & Chief HR Officer holding 14,877 shares of WST after the transaction. In another insider transaction, Reiss-Clark Cindy sold 3,477 shares at $393.34 per share on Aug 22. Company shares held by the Chief Commercial Officer now total 4,320.

Dividend

It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. West Pharmaceutical Services, Inc. pays an annual dividend of $0.59, resulting in a dividend yield of 0.15%, and it has a price to earnings (P/E) ratio of 53.65. WST’s most recent ex-dividend date was 1/30/2024 when it declared a $0.20 quarterly dividend that was paid in cash on 2/7/2024. Previously, the company paid the dividend on 11/15/2023 with an ex-dividend date of 11/7/2023. The WST stock dividend was $0.20 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for WST in the last 3 months, the mean price target is $382.46 with high estimates of $440.00 and low estimates of $323.00. In terms of 52-week highs and lows, WST has a high of $415.73 and a low of $264.02.

As of this writing, WST has an earnings estimate of $1.78 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $1.86 per share and a lower estimate of $1.73. The company reported an EPS of $2.11 in the last quarter, which was 9.30% higher than expectations of $1.93.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. WST’s latest balance sheet shows that the firm has $762.60M in Cash & Short Term Investments as of fiscal 2021. There were $325.30M in debt and $594.10M in liabilities at the time. Its Book Value Per Share was $38.76, while its Total Shareholder’s Equity was $2.34B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for WST is Buy with a score of 4.14.

Most Popular

Related Posts